After Serum Institute, Bharat Biotech reduces Covaxin price to Rs 400 for states Ruchika Sharma30 April 2021 1:00 PM ISTNew Delhi: Bharat Biotech on Thursday announced a cut in the price of its COVID-19 vaccine ''Covaxin'' it plans to sell to the states to Rs 400...
Plea asks to direct Serum Institute, Bharat Biotech sell vaccines at uniform rate of Rs 150 Ruchika Sharma29 April 2021 10:00 AM ISTMumbai: A public interest litigation (PIL) has been filed in the Bombay High Court challenging the different rates for COVID-19 vaccines for the...
Covishield, Covaxin effective against Indian strain of Covid-19, claims study Ruchika Sharma28 April 2021 2:55 PM ISTNew Delhi: Covishield and Covaxin -- the two coronavirus vaccines currently in use in India -- have efficacy against the 'Indian strain' and show...
COVID Vaccination in India- Developments and Controversies Medical Dialogues Team26 April 2021 8:08 PM ISTNew Delhi: Engulfed by a calamitous coronavirus wave, the Government rolled out anti-COVID vaccines for the immunization programme against the deadly...
Bharat Biotech seeks DCGI nod for extension of Covaxin shelf life from 6 to 24 months Ruchika Sharma26 April 2021 12:48 PM ISTNew Delhi: Bharat Biotech has written to India's drug regulator seeking extension of the shelf-life of its indigenously developed Covid-19 vaccine...
Bharat Biotech Covaxin shows 78 percent overall interim efficacy, 100 percent efficacy against severe Covid Ruchika Sharma22 April 2021 11:30 AM ISTHyderabad: Drugmaker, Bharat Biotech, has recently announced phase 3 interim analysis results of COVAXIN. The second interim analysis is based...
Severity, Virulence In 2nd Wave Same As 1st Wave: Centre Releases COVID-19 Data Garima21 April 2021 11:13 PM ISTNew Delhi: Amid a staggering surge in COVID-19 cases across the country, the Centre on Wednesday sought to quell the panic by presenting a slew of...
Bharat Biotech to expand Covaxin production capacity to 700 million doses annually Ruchika Sharma21 April 2021 10:30 AM ISTHyderabad: Bharat Biotech recently announced that it has scaled up its COVID-19 vaccine Covaxin manufacturing capacity to 700 million doses per...
Serum Institute, Bharat Biotech to get Rs 45.67 billion to boost Covid-19 vaccine production capacity Ruchika Sharma20 April 2021 10:30 AM ISTNew Delhi: India's government has approved a 45.67-billion-rupee ($610 million) grant for COVID-19 vaccine makers Serum Institute of India (SII) and...
Remdesivir production being doubled to 74.1 lakh per month by May: Dr Harsh Vardhan Ruchika Sharma19 April 2021 12:39 PM ISTNew Delhi: Union Health Minister Harsh Vardhan on Sunday said there will be a 10 times rise in Covaxin vaccine production by September while...
Haffkine Institute secures Govt nod to manufacture Covaxin Ruchika Sharma16 April 2021 3:42 PM ISTMumbai: The Union government has given its permission to the city-based Haffkin Institute to manufacture Covaxin, an anti-coronavirus vaccine of...
India to have 5 more COVID vaccines by Oct Ruchika Sharma12 April 2021 12:02 PM ISTThese vaccines are Sputnik V vaccine, Johnson and Johnson vaccine, Novavax vaccine, Zydus Cadila's vaccine, and Bharat Biotech's Intranasal Vaccine.
